6 Papers
Na Ning is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Serine metabolism antagonizes antiviral innate immunity by preventing ATP6V0d2-mediated YAP lysosomal degradation
Long Shen,Penghui Hu,Yanan Zhang,Zemin Ji,Xiao Shan,Lina Ni,Na Ning,Jing Wang,He Tian,Guanghou Shui,Yukang Yuan,Guoli Li,Hui Zheng,Xiang-Ping Yang,Dandan Huang,Xiangling Feng,Mulin Jun Li,Zhe Liu,Ting Wang,Qiujing Yu +19 more
TL;DR: In this article, the authors demonstrate that virus-infected macrophages display decreased expression of serine synthesis pathway (SSP) enzymes, and also suggest manipulation of SSP metabolism as a therapeutic strategy against virus infection.
90
Plant Peroxisome-Targeting Effector MoPtep1 Is Required for the Virulence of Magnaporthe oryzae
TL;DR: It is proved that MoPtep1 was induced in the early stage of the M. oryzae infection and positively regulated the pathogenicity, while it did not affect the vegetative growth of mycelia.
18
Glycosylphosphatidylinositol Anchor Biosynthesis Pathway-Related Protein GPI7 Is Required for the Vegetative Growth and Pathogenicity of Colletotrichum graminicola
TL;DR: The results suggested that CgGPI7 is required for vegetative growth and pathogenicity and might depend on the cell wall integrity of C. graminicola.
The Anti-Cancer Effects of Mitochondrial-Targeted Triphenylphosphonium–Resveratrol Conjugate on Breast Cancer Cells
Lingling Jiang,Han Yu,Chenwei Wang,Fujin He,Zhongqi Shi,Haohong Tu,Na Ning,Shaofeng Duan,Yunqi Zhao +8 more
TL;DR: TPP-resveratrol significantly improved cytotoxicity in 4T1 cells and MDA-MB-231 cells by inducing apoptosis and mitochondrial membrane potential loss and is suggested to be an effective agent for breast cancer treatment.
Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer.
Huicheng Liu,Bai Lili,Liu Huang,Na Ning,Lin Li,Yijia Li,Xuejiao Dong,Qiuyang Du,Minghui Xia,Yufei Chen,Zhao Likun,Li Yanhu,Meng Qingwu,Jing Wang,Yaqi Duan,Jie Ming,Andy Qingan Yuan,Xiang-Ping Yang +17 more
TL;DR: In this article, a bispecific antibody F7AK3 was developed to recognize both trophoblast cell surface antigen 2 (TROP2) and CD3 and evaluated its antitumor activities both in vitro and in vivo.